Protective ischaemia in patients: preconditioning and postconditioning

• Authors: Asger Granfeldt, Aarhus University; David J. Lefer, Emory University; Jakob Vinten-Johansen, Emory University
• Journal Title: Cardiovascular Research
• Volume: Volume 83, Number 2
• Publisher: Oxford University Press | 2009-07-15, Pages 234-246
• Type of Work: Article | Post-print: After Peer Review
• Publisher DOI: http://doi.org/10.1093/cvr/cvp129
• Subjects: Health Sciences, General
• Keywords: Preconditioning; Postconditioning; Infarct size; Myocardial protection; Coronary intervention; Cardiac surgery

Abstract

Infarct size can be limited by reducing the determinants of infarct size or increasing collateral blood flow by treatment initiated before the ischaemic event. Reperfusion is the definitive treatment for permanently reducing infarct size and restoring some degree of contractile function to the affected myocardium. Innate survival mechanisms in the heart can be stimulated by short, non-lethal periods of ischaemia and reperfusion, applied either before or after the ischaemic event. Preconditioning, a series of transient intervals of ischaemia and reperfusion applied before the lethal ‘index’ ischaemic event, sets in motion molecular and cellular mechanisms that increase cardiomyocyte survival to a degree that had not hitherto been seen before. The cardioprotective ischaemic-reperfusion protocol applied at onset of reperfusion, termed ‘postconditioning’ (Postcon), is also associated with significant cardioprotection that can be applied at the point of reperfusion treatment in the catheterization laboratory or operating room. Both preconditioning and Postcon have been successfully applied to the clinical setting and have been found to reduce infarct size and other attributes of post-ischaemic injury. This review will summarize the physiological preclinical data on preconditioning and Postcon that are relevant to their translation to clinical therapeutics and treatment.